1/28/2025 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $11.00 ➝ $10.00 | |
1/24/2025 | Mizuho | Lower Target | Outperform ➝ Outperform | $7.00 ➝ $6.00 | |
1/23/2025 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $11.00 ➝ $10.00 | |
1/22/2025 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $9.00 ➝ $8.00 | |
1/17/2025 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $5.00 ➝ $4.00 | |
1/16/2025 | Truist Financial | Lower Target | Buy ➝ Buy | $8.00 ➝ $7.00 | |
12/17/2024 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $10.00 ➝ $9.00 | |
12/17/2024 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $7.00 | |
11/25/2024 | Bank of America | Initiated Coverage | Buy | $6.00 | |
11/22/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $10.00 ➝ $8.00 | |
11/21/2024 | Guggenheim | Lower Target | Buy ➝ Buy | $8.00 ➝ $7.00 | |
11/15/2024 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $8.00 ➝ $7.00 | |
11/13/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $7.00 ➝ $5.00 | |
11/13/2024 | TD Cowen | Boost Target | Buy ➝ Buy | $9.50 ➝ $11.00 | |
10/17/2024 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $14.00 ➝ $12.00 | |
10/14/2024 | Wells Fargo & Company | Initiated Coverage | Equal Weight | $46.00 | |
10/10/2024 | Barclays | Reiterated Rating | Equal Weight ➝ Equal Weight | $7.00 ➝ $7.00 | |
10/3/2024 | Citigroup | Upgrade | Sell ➝ Neutral | $5.00 ➝ $5.50 | |
9/17/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $12.00 ➝ $12.00 | |
9/10/2024 | Piper Sandler | Boost Target | Overweight ➝ Overweight | $8.00 ➝ $10.00 | |
9/6/2024 | Roth Mkm | Lower Target | Neutral ➝ Neutral | $7.00 ➝ $6.00 | |
9/6/2024 | Truist Financial | Lower Target | Buy ➝ Buy | $10.00 ➝ $8.00 | |
9/6/2024 | Royal Bank of Canada | Reiterated Rating | Outperform ➝ Outperform | $11.00 ➝ $11.00 | |
9/4/2024 | Jefferies Financial Group | Initiated Coverage | Hold | $5.00 | |
8/8/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $10.00 ➝ $7.00 | |
8/8/2024 | Northland Securities | Lower Target | Underperform ➝ Underperform | $6.00 ➝ $4.00 | |
8/7/2024 | Roth Capital | Downgrade | Hold ➝ Strong Sell | | |
8/7/2024 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $23.00 ➝ $19.00 | |
8/7/2024 | UBS Group | Lower Target | Buy ➝ Buy | $12.00 ➝ $9.00 | |
8/7/2024 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $12.00 ➝ $10.00 | |
8/7/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $11.00 ➝ $8.00 | |
8/7/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $14.00 ➝ $12.00 | |
8/7/2024 | BNP Paribas | Downgrade | Outperform ➝ Neutral | $15.00 ➝ $7.00 | |
7/18/2024 | UBS Group | Lower Target | Buy ➝ Buy | $20.00 ➝ $12.00 | |
7/18/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $12.00 ➝ $10.00 | |
7/16/2024 | JPMorgan Chase & Co. | Boost Target | Overweight ➝ Overweight | $21.00 ➝ $23.00 | |
7/8/2024 | Royal Bank of Canada | Lower Target | Outperform ➝ Outperform | $15.00 ➝ $13.00 | |
7/2/2024 | Citigroup | Downgrade | Buy ➝ Sell | $15.00 ➝ $5.00 | |
5/9/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $13.00 ➝ $12.00 | |
5/8/2024 | Northland Capmk | Downgrade | Hold ➝ Strong Sell | | |
5/8/2024 | Cantor Fitzgerald | Lower Target | Overweight ➝ Overweight | $24.00 ➝ $14.00 | |
5/8/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $14.00 ➝ $11.00 | |
5/8/2024 | Northland Securities | Reiterated Rating | Market Perform ➝ Underperform | $12.00 ➝ $6.00 | |
5/8/2024 | Mizuho | Lower Target | Buy ➝ Buy | $16.00 ➝ $13.00 | |
5/8/2024 | TD Cowen | Lower Target | Buy ➝ Buy | $15.00 ➝ $11.00 | |
5/8/2024 | Roth Mkm | Downgrade | Buy ➝ Neutral | $15.00 ➝ $8.00 | |
5/7/2024 | Roth Capital | Downgrade | Buy ➝ Neutral | | |
5/7/2024 | Roth Mkm | Lower Target | Buy ➝ Buy | $20.00 ➝ $15.00 | |
4/19/2024 | Mizuho | Lower Target | Buy ➝ Buy | $18.00 ➝ $16.00 | |
4/11/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $16.00 ➝ $14.00 | |
3/13/2024 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $24.00 | |
3/5/2024 | Barclays | Lower Target | Equal Weight ➝ Equal Weight | $15.00 ➝ $13.00 | |
3/1/2024 | UBS Group | Lower Target | Buy ➝ Buy | $28.00 ➝ $20.00 | |
3/1/2024 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $26.00 ➝ $23.00 | |
2/29/2024 | Cantor Fitzgerald | Lower Target | Overweight ➝ Overweight | $28.00 ➝ $24.00 | |
2/29/2024 | Royal Bank of Canada | Lower Target | Outperform ➝ Outperform | $20.00 ➝ $17.00 | |
2/29/2024 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $32.00 ➝ $26.00 | |
2/29/2024 | Oppenheimer | Lower Target | Outperform ➝ Outperform | $42.00 ➝ $17.00 | |
2/29/2024 | Truist Financial | Reiterated Rating | Buy ➝ Buy | $23.00 ➝ $20.00 | |
2/29/2024 | Mizuho | Reiterated Rating | Buy ➝ Buy | $19.00 ➝ $18.00 | |
2/29/2024 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $20.00 ➝ $16.00 | |
2/29/2024 | TD Cowen | Lower Target | Outperform | $30.00 ➝ $22.00 | |
2/14/2024 | Royal Bank of Canada | Initiated Coverage | Outperform | $20.00 | |
1/22/2024 | Barclays | Upgrade | Underweight ➝ Equal Weight | $17.00 ➝ $15.00 | |
1/19/2024 | Janney Montgomery Scott | Initiated Coverage | Buy | $20.00 | |
1/3/2024 | Mizuho | Boost Target | Buy ➝ Buy | $18.00 ➝ $19.00 | |
12/8/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $21.00 ➝ $17.00 | |
11/21/2023 | Mizuho | Initiated Coverage | Buy | $18.00 | |
11/9/2023 | Truist Financial | Lower Target | Buy ➝ Buy | $25.00 ➝ $23.00 | |
11/8/2023 | Cantor Fitzgerald | Reiterated Rating | Overweight ➝ Overweight | $28.00 | |
10/20/2023 | BNP Paribas | Initiated Coverage | Outperform | $33.00 | |
10/19/2023 | JPMorgan Chase & Co. | Lower Target | Overweight ➝ Overweight | $38.00 ➝ $32.00 | |
10/18/2023 | Citigroup | Lower Target | Buy ➝ Buy | $34.00 ➝ $26.00 | |
10/17/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $22.00 ➝ $21.00 | |
10/11/2023 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $27.00 ➝ $28.00 | |
10/6/2023 | Piper Sandler | Upgrade | Neutral ➝ Overweight | $28.00 | |
10/5/2023 | Northland Securities | Downgrade | Outperform ➝ Market Perform | $26.00 ➝ $18.00 | |
10/4/2023 | Truist Financial | Lower Target | Buy ➝ Buy | $30.00 ➝ $25.00 | |
9/12/2023 | Truist Financial | Lower Target | Buy ➝ Buy | $35.00 ➝ $30.00 | |
9/6/2023 | Morgan Stanley | Lower Target | Equal Weight ➝ Equal Weight | $28.00 ➝ $22.00 | |
9/5/2023 | Cantor Fitzgerald | Upgrade | Neutral ➝ Overweight | $27.00 ➝ $28.00 | |
8/4/2023 | Barclays | Boost Target | Underweight ➝ Underweight | $19.00 ➝ $20.00 | |
8/2/2023 | Oppenheimer | Reiterated Rating | Outperform ➝ Outperform | $42.00 | |
7/19/2023 | JPMorgan Chase & Co. | Boost Target | | $35.00 ➝ $38.00 | |
5/9/2023 | Truist Financial | Boost Target | | $32.00 ➝ $35.00 | |
5/9/2023 | Cantor Fitzgerald | Lower Target | | $30.00 ➝ $27.00 | |
5/9/2023 | Northland Securities | Upgrade | Market Perform ➝ Outperform | $30.00 | |
5/9/2023 | Guggenheim | Upgrade | Neutral ➝ Buy | $30.00 | |
5/2/2023 | Barclays | Downgrade | Equal Weight ➝ Underweight | $27.00 ➝ $19.00 | |
4/3/2023 | Morgan Stanley | Lower Target | Equal Weight | $32.00 ➝ $29.00 | |
3/30/2023 | The Goldman Sachs Group | Upgrade | Sell ➝ Neutral | $20.00 ➝ $22.00 | |
3/17/2023 | Barclays | Lower Target | | $30.00 ➝ $27.00 | |
3/9/2023 | Citigroup | Initiated Coverage | Buy | $34.00 | |
3/6/2023 | Credit Suisse Group | Reiterated Rating | Outperform | $29.00 | |
3/1/2023 | Northland Securities | Downgrade | Outperform ➝ Market Perform | $30.00 ➝ $27.00 | |
2/27/2023 | Truist Financial | Boost Target | Buy | $30.00 ➝ $32.00 | |
1/25/2023 | Cantor Fitzgerald | Initiated Coverage | Neutral | $30.00 | |
1/20/2023 | Cowen | Lower Target | Outperform | $37.50 ➝ $35.00 | |
1/17/2023 | Credit Suisse Group | Boost Target | Outperform | $26.00 ➝ $29.00 | |
1/10/2023 | Morgan Stanley | Lower Target | Equal Weight | $36.00 ➝ $32.00 | |
12/8/2022 | JPMorgan Chase & Co. | Boost Target | | $35.00 ➝ $36.00 | |
11/17/2022 | Oppenheimer | Boost Target | | $41.00 | |
11/16/2022 | Barclays | Boost Target | Equal Weight | $25.00 ➝ $30.00 | |
11/15/2022 | JPMorgan Chase & Co. | Boost Target | Overweight | $32.00 ➝ $35.00 | |
11/15/2022 | The Goldman Sachs Group | Boost Target | Sell | $18.00 ➝ $20.00 | |
11/15/2022 | Northland Securities | Upgrade | Market Perform ➝ Outperform | $30.00 | |
11/15/2022 | Piper Sandler | Boost Target | Neutral | $28.00 ➝ $30.00 | |
10/20/2022 | JPMorgan Chase & Co. | Lower Target | Overweight | $35.00 ➝ $32.00 | |
9/22/2022 | Morgan Stanley | Boost Target | Equal Weight | $33.00 ➝ $36.00 | |
9/16/2022 | Cowen | Upgrade | Market Perform ➝ Outperform | $29.00 ➝ $37.50 | |
9/16/2022 | Cowen | Upgrade | Market Perform ➝ Outperform | $29.00 ➝ $37.50 | |
9/9/2022 | Guggenheim | Downgrade | Buy ➝ Neutral | | |
9/7/2022 | The Goldman Sachs Group | Downgrade | Buy ➝ Sell | $23.00 ➝ $21.00 | |
8/18/2022 | Morgan Stanley | Boost Target | Equal Weight | $21.00 ➝ $33.00 | |
8/16/2022 | Roth Capital | Boost Target | | $20.00 ➝ $40.00 | |
8/16/2022 | Truist Financial | Boost Target | Buy | $25.00 ➝ $30.00 | |
8/16/2022 | Barclays | Boost Target | Equal Weight | $24.00 ➝ $25.00 | |
8/8/2022 | JPMorgan Chase & Co. | Boost Target | Overweight | $31.00 ➝ $35.00 | |
8/5/2022 | Barclays | Initiated Coverage | Equal Weight | $24.00 | |
7/25/2022 | Credit Suisse Group | Lower Target | Outperform | $25.00 ➝ $20.00 | |
7/20/2022 | JPMorgan Chase & Co. | Boost Target | | $27.00 ➝ $31.00 | |
7/19/2022 | Northland Securities | Downgrade | Outperform ➝ Market Perform | | |
7/19/2022 | Piper Sandler | Boost Target | Neutral | $15.00 ➝ $20.00 | |
6/20/2022 | The Goldman Sachs Group | Boost Target | Buy | $19.00 ➝ $22.00 | |
6/13/2022 | Morgan Stanley | Lower Target | Equal Weight | $25.00 ➝ $21.00 | |
6/9/2022 | UBS Group | Boost Target | | $27.00 | |
6/9/2022 | Truist Financial | Upgrade | Hold ➝ Buy | $16.00 ➝ $25.00 | |
5/18/2022 | Truist Financial | Lower Target | NA | $20.00 ➝ $16.00 | |
5/18/2022 | Credit Suisse Group | Lower Target | | $31.00 ➝ $25.00 | |
5/17/2022 | Piper Sandler | Lower Target | NA | $15.00 | |
5/17/2022 | Oppenheimer | Lower Target | NA | $40.00 | |
5/17/2022 | Cowen | Lower Target | NA | $20.00 | |
5/17/2022 | Guggenheim | Lower Target | NA | $22.00 ➝ $19.00 | |
5/10/2022 | Northland Securities | Initiated Coverage | Outperform | $16.00 | |
4/19/2022 | JPMorgan Chase & Co. | Lower Target | Overweight | $35.00 ➝ $33.00 | |
4/8/2022 | Piper Sandler | Downgrade | Overweight ➝ Neutral | $26.00 ➝ $16.00 | |
3/30/2022 | Colliers Securities | Reiterated Rating | Neutral | | |
3/22/2022 | Morgan Stanley | Lower Target | Equal Weight | $27.00 ➝ $25.00 | |
3/11/2022 | Piper Sandler | Lower Target | Overweight | $39.00 ➝ $26.00 | |
3/11/2022 | Guggenheim | Upgrade | Neutral ➝ Buy | $22.00 | |
1/24/2022 | Truist Financial | Lower Target | Hold | $34.00 ➝ $20.00 | |
1/20/2022 | JPMorgan Chase & Co. | Lower Target | | $43.00 ➝ $37.00 | |
1/13/2022 | Morgan Stanley | Lower Target | Equal Weight | $34.00 ➝ $27.00 | |
1/7/2022 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $42.00 ➝ $39.00 | |
11/10/2021 | Roth Capital | Lower Target | Buy | $44.00 ➝ $37.00 | |
11/10/2021 | Barclays | Lower Target | Equal Weight | $32.00 ➝ $29.00 | |
10/20/2021 | Guggenheim | Downgrade | Buy ➝ Neutral | | |
10/15/2021 | Truist Financial | Initiated Coverage | Hold | $34.00 | |
8/19/2021 | Morgan Stanley | Boost Target | Equal Weight | $31.00 ➝ $34.00 | |
7/21/2021 | JPMorgan Chase & Co. | Boost Target | Average ➝ Overweight | $42.00 ➝ $46.00 | |
7/2/2021 | The Goldman Sachs Group | Boost Target | Buy | $33.00 ➝ $36.00 | |
6/29/2021 | Piper Sandler | Initiated Coverage | Overweight | $43.00 | |
5/26/2021 | Morgan Stanley | Lower Target | Equal Weight | $32.00 ➝ $31.00 | |
5/24/2021 | Credit Suisse Group | Upgrade | Neutral ➝ Outperform | $40.00 | |
5/19/2021 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $36.00 ➝ $33.00 | |
5/4/2021 | Cowen | Lower Target | Market Perform | $40.00 ➝ $31.00 | |
4/28/2021 | Barclays | Reiterated Rating | Overweight ➝ Equal Weight | $49.00 ➝ $35.00 | |
4/22/2021 | Barclays | Downgrade | Overweight ➝ Equal Weight | $35.00 | |
3/22/2021 | Johnson Rice | Initiated Coverage | Buy | $43.00 | |
3/11/2021 | Roth Capital | Initiated Coverage | In-Line ➝ Buy | $38.00 | |
3/10/2021 | Morgan Stanley | Lower Target | Equal Weight | $41.00 ➝ $32.00 | |
3/8/2021 | JPMorgan Chase & Co. | Lower Target | Overweight | $44.00 ➝ $40.00 | |
2/22/2021 | Oppenheimer | Initiated Coverage | Outperform | $46.00 | |
2/22/2021 | UBS Group | Initiated Coverage | Buy | $48.00 | |
2/22/2021 | JPMorgan Chase & Co. | Initiated Coverage | Overweight | $44.00 | |
2/22/2021 | Morgan Stanley | Initiated Coverage | Equal Weight | $41.00 | |
2/22/2021 | Credit Suisse Group | Initiated Coverage | Neutral | $40.00 | |
2/22/2021 | Cowen | Initiated Coverage | Outperform | $39.00 | |
2/22/2021 | The Goldman Sachs Group | Initiated Coverage | Neutral | $30.00 | |
2/22/2021 | Guggenheim | Initiated Coverage | Buy | $48.00 | |
2/22/2021 | Barclays | Initiated Coverage | Overweight | $49.00 | |